Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Interferon-α as an appropriate model of substance-induced depression.

Galvão-de Almeida A, Miranda-Scippa A, De Oliveira IR, Quarantini L.

Psychosomatics. 2011 Jan-Feb;52(1):95. doi: 10.1016/j.psym.2010.11.004. No abstract available.

PMID:
21300205
2.

Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.

Bannink M, Kruit WH, Van Gool AR, Sleijfer S, van der Holt B, Eggermont AM, Stoter G, Hengeveld MW.

Psychosomatics. 2008 Jan-Feb;49(1):56-63. doi: 10.1176/appi.psy.49.1.56.

PMID:
18212177
3.
4.

Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.

Navinés R, Gómez-Gil E, Puig S, Baeza I, De Pablo J, Martín-Santos R.

Eur J Dermatol. 2009 Nov-Dec;19(6):611-5. doi: 10.1684/ejd.2009.0787. Epub 2009 Aug 26.

PMID:
19709980
5.

Grand mal seizure induced by interferon-alpha-2b.

Kors C, Milling A, Hofmann M, Sterry W, Trefzer U.

J Eur Acad Dermatol Venereol. 2006 Apr;20(4):473-4. No abstract available.

PMID:
16643159
6.

[Depression during interferon therapy in renal cell cancer patients--comparison with chronic hepatitis C patients].

Sakamoto H, Inoue K, Shimada M, Yoshida H, Otsubo T, Miyaoka H, Kamizima K, Ishii M, Mitamura K.

Nihon Hinyokika Gakkai Zasshi. 2000 Sep;91(9):611-7. Japanese.

7.

The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.

Zincke MT, Kurani A, Istafanous R, Kellner C.

J ECT. 2007 Dec;23(4):291-2.

PMID:
18090708
8.

Methylphenidate for alpha-interferon induced depression.

Camacho A, Ng B.

J Psychopharmacol. 2006 Sep;20(5):687-9. Epub 2006 Mar 13.

PMID:
16533869
9.

Livedo reticularis associated with interferon alpha therapy in two melanoma patients.

Ruiz-Genao DP, García-F-Villalta MJ, Hernández-Núñez A, Ríos-Buceta L, Fernández-Herrera J, García-Díez A.

J Eur Acad Dermatol Venereol. 2005 Mar;19(2):252-4.

PMID:
15752306
10.

Lipoatrophy associated with interferon alfa adjuvant therapy for melanoma.

Vallés L, González M, Polo I, Enguita AB, Vanaclocha F, Ortiz-Romero PL.

Arch Dermatol. 2009 Jan;145(1):98-9. doi: 10.1001/archdermatol.2008.531. No abstract available.

PMID:
19153363
11.

Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.

Heinze S, Egberts F, Rötzer S, Volkenandt M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Hinzpeter A, Hauschild A, Schaefer M.

J Immunother. 2010 Jan;33(1):106-14. doi: 10.1097/CJI.0b013e3181b8bdb9.

PMID:
19952950
12.

Is the interferon-α-triggered depressive episode a self-limited kind of depression? Four cases of persistent affective symptoms after antiviral treatment in HCV-infected individuals.

Galvão-de Almeida A, Quarantini LC, Batista-Neves S, Lyra AC, Paraná R, de Oliveira IR, Miranda-Scippa A, Guindalini C.

World J Biol Psychiatry. 2010 Oct;11(7):914-8. doi: 10.3109/15622975.2010.504282.

PMID:
20642400
13.

Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.

Dell'Osso L, Pini S, Maggi L, Rucci P, Del Debbio A, Carlini M, Baldini A, Ferrari G, Manca E, Beverini E, Amore M, Scarallo V, Semeraro Q, Brunetto M, Bonino F, Maj M.

J Psychosom Res. 2007 Mar;62(3):349-55.

PMID:
17324686
14.

Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.

Mahajan S, Avasthi A, Grover S, Chawla YK.

J Psychosom Res. 2014 Aug;77(2):109-15. doi: 10.1016/j.jpsychores.2014.05.008. Epub 2014 Jun 2.

PMID:
25077851
15.

Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.

Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, Langohr K, Solà R, Vieta E, Martín-Santos R.

J Clin Psychiatry. 2012 Aug;73(8):1128-38. doi: 10.4088/JCP.12r07694. Review.

PMID:
22967776
16.

Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.

Sockalingam S, Balderson K.

Int Clin Psychopharmacol. 2005 Sep;20(5):289-90.

PMID:
16096520
17.

Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.

Friebe A, Schwarz MJ, Schmid-Wendtner M, Volkenandt M, Schmidt F, Horn M, Janssen G, Schaefer M.

J Immunother. 2007 Apr;30(3):333-7.

PMID:
17414324
18.

Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.

Ammoury A, El Sayed F, Farah C, Bazex J.

J Am Acad Dermatol. 2008 Mar;58(3):532-3. doi: 10.1016/j.jaad.2006.10.983. No abstract available.

PMID:
18280369
19.

Differences in depressive thoughts between major depressive disorder, IFN-alpha-induced depression, and depressive disorders among cancer patients.

Pasquini M, Speca A, Mastroeni S, Delle Chiaie R, Sternberg CN, Biondi M.

J Psychosom Res. 2008 Aug;65(2):153-6. doi: 10.1016/j.jpsychores.2008.01.009. Epub 2008 May 21.

PMID:
18655860
20.

Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186).

Sulkes A, Schachter J.

Ann Oncol. 2002 Apr;13(4):637. No abstract available.

PMID:
12056717

Supplemental Content

Support Center